Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase

Cardiovascular Research

Volumn 69, Issue 3, 2006, Pages 736-745

  Spallarossa, Paolo ^a   Altieri, Paola ^a   Garibaldi, Silvano ^a   Ghigliotti, Giorgio ^a   Barisione, Chiara ^a   Manca, Valeria ^a   Fabbi, Patrizia ^a   Ballestrero, Alberto ^b   Brunelli, Claudio ^a   Barsotti, Antonio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

MAP kinase; Matrix metalloproteinases; Myocytes; NADPH oxidase; Oxygen radicals

Indexed keywords

CARVEDILOL; DOXORUBICIN; ENZYME INHIBITOR; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RAZOXANE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART FAILURE; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANTHRACENES; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; BLOTTING, WESTERN; CARBAZOLES; CATECHOLAMINES; CELL LINE; DOXORUBICIN; ENZYME ACTIVATION; FLAVONOIDS; HUMANS; IMIDAZOLES; IMIDAZOLINES; JANUS KINASE 1; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; NADPH OXIDASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROPANOLAMINES; PROTEIN-TYROSINE KINASES; PYRIDINES; RAZOXANE;

EID: 31344453935     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.08.009     Document Type: Article

References (42)

1. H. Nagase, and J.F. Woessner Jr. Matrix metalloproteinases J Biol Chem 274 1999 21491 21494
2. S. Rajagopalan, X.P. Meng, S. Ramasamy, D.G. Harrison, and Z.S. Galis Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability J Clin Invest 98 1996 2572 2579
3. D.A. Siwik, P.J. Pagano, and W.S. Colucci Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts Am J Physiol Cell Physiol 280 2001 C53 C60
4. N. Inoue, S. Takeshita, D. Gao, T. Ishida, S. Kawashima, and H. Akita Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NAD(P)H oxidase in cultured aortic endothelial cells Atherosclerosis 155 2001 45 52
5. K. Grote, I. Flach, M. Luchtefeld, E. Akin, S.M Holland, and H. Drexler Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species Circ Res 92 2003 80 86
6. M.L. Coker, C.V. Thomas, M.J. Clair, J.W. Hendrick, R.S. Krombach, and Z.S. Galis Myocardial matrix metalloproteinase activity and abundance with congestive heart failure Am J Physiol 274 5 Pt 2 1998 H1516 H1523
7. C.V. Thomas, M.L. Coker, J.L. Zellner, J.R. Handy, A.J. Crumbley III, and F.G. Spinale Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy Circulation 97 1998 1708 1715
8. Y.Y. Li, A.M. Feldman, Y. Sun, and C.F. McTiernan Differential expression of tissue inhibitors of metalloproteinases in the failing human heart Circulation 98 1998 1728 1734
9. F.G. Spinale Matrix metalloproteinases: regulation and dysregulation in the failing heart Circ Res 90 2002 520 530
10. K. Shan, A.M. Lincoff, J.B. Young, and J.B. Young Anthracycline-induced cardiotoxicity Ann Intern Med 125 1996 47 58
11. P.K. Singal, T. Li, D. Kumar, I. Danelisen, and N. Iliskovic Adriamycin-induced heart failure: mechanism and modulation Mol Cell Biochem 207 2000 77 86
12. P. Spallarossa, S. Garibaldi, P. Altieri, P. Fabbi, V. Manca, and S. Nasti Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro J Mol Cell Cardiol 37 2004 837 846
13. W. Zhu, Y. Zou, R. Aikawa, K. Harada, S. Kudoh, and H. Uozumi MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes Circulation 100 1999 2100 2107
14. Y.J. Kang, Z.X. Zhou, G.W. Wang, A. Buridi, and J.B. Klein Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases J Biol Chem 275 2000 13690 13698
15. P. Bai, J.G. Mabley, L. Liaudet, L. Virag, C. Szabo, and P. Pacher Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity Oncol Rep 11 2004 505 508
16. van Dalen EC, Caron HN, Dickinson HO, Kremer LCM. Cardioprotective interventions for cancer patients receiving anthracyclines. The Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD003917.
17. P.J. Oliveira, J.A. Bjork, M.S. Santos, R.L. Leino, M.K. Froberg, and A.J. Moreno Carvedilol- mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity Toxicol Appl Pharmacol 200 2004 159 168
18. T. Bleeke, H. Zhang, N. Madamanchi, C. Patterson, and J. Faber Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species Circ Res 94 2004 37 45
19. B.B. Hasinoff, K.L. Schnabl, R.A. Marusak, D. Patel, and E. Huebner Dexrazoxane (ICRF-187) protects cardiac myocytes against doxorubicin by preventing damage to mitochondria Cardiovasc Toxicol 3 2003 89 99
20. B.W. Wang, H. Chang, S. Lin, P. Kuan, and K.G. Shyu Induction of matrix metalloproteinases-14 and -2 by cyclical mechanical stretch is mediated by tumor necrosis factor-alpha in cultured human umbilical vein endothelial cells Cardiovasc Res 59 2003 460 469
21. J.A. Royall, and H. Ischiropoulos Evaluation of 2′,7′- dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells Arch Biochem Biophys 302 1993 348 355
22. M.L. Coker, J.R. Jolly, C. Joffs, T. Etoh, J.R. Holder, and B.R. Bond FG matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation Am J Physiol Heart Circ Physiol 281 2001 H543 H551
23. P. Altieri, C. Brunelli, S. Garibaldi, A. Nicolino, S. Ubaldi, and P. Spallarossa Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure Eur J Clin Invest 33 2003 648 656
24. V.L. Gabai, A.B. Meriin, J.A. Yaglom, J.Y. Wei, D.D. Mosser, and M.Y. Sherman Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation. HSP72 alleviates the stews-induced inhibition of JNK dephosphorylation J Biol Chem 275 2000 38088 38094
25. F.G. Spinale, M.L. Coker, C.V. Thomas, J.D. Walker, R. Mukherjee, and L. Hebbarm Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function Circ Res 82 1998 482 495
26. R.L. Juliano, and S. Haskill Signal transduction from the extracellular matrix J Cell Biol 120 1993 577 585
27. H.E. Kim, S.S. Dalal, E. Young, M.J. Legato, M.L. Weisfeldt, and J. D'Armiento Disruption of the myocardial extracellular matrix leads to cardiac dysfunction J Clin Invest 106 2000 857 866
28. K.K. Griendling Novel NAD(P)H oxidases in the cardiovascular system Heart 90 2004 491 493
29. B. Lassegue, D. Sorescu, K. Szocs, Q. Yin, M. Akers, and Y. Zhang Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways Circ Res 88 2001 888 894
30. F.A. van de Loo, M.B. Bennink, O.J. Arntz, R.L. Smeets, E. Lubberts, and L.A. Joosten Deficiency of NAD(P)H oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models Am J Pathol 163 2003 1525 1537
31. T. Finkel, and N.J. Holbrook Oxidants, oxidative stress and the biology of ageing Nature 408 2000 239 247
32. Q. Liang, and J.D. Molkentin Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models J Mol Cell Cardiol 35 2003 1385 1394
33. J.A Yaglom, D. Ekhterae, V.L. Gabai, and M.Y. Sherman Regulation of necrosis of H9c2 myogenic cells upon transient energy deprivation. Rapid deenergization of mitochondria precedes necrosis and is controlled by reactive oxygen species, stress kinase JNK, HSP72 and ARC J Biol Chem 278 2003 50483 50496
34. N.A. Turner, F. Xia, G. Azhar, X. Zhang, L. Liu, and J.Y. Wei Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells J Mol Cell Cardiol 30 1998 1789 1901
35. G. Corna, P. Santambrogio, G. Minotti, and G. Cairo Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: role of reactive oxygen species and ferritin J Biol Chem 279 2004 13738 13745
36. H. Matsui, I. Morishima, Y. Numaguchi, Y. Toki, K. Okumura, and T. Hayakawa Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats Life Sci 65 1999 1265 1274
37. W.H. Frishman, and Carvedilol N Engl J Med 339 1998 1759 1765
38. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda Carvedilol Or Metoprolol European Trial Investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
39. T.L. Yue, X.L. Ma, X. Wang, A.M. Romanic, G.L. Liu, and C. Louden Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol Circ Res 82 1998 166 174
40. W. Briest, A. Holzl, B. Rassler, A. Deten, M. Leicht, and H.A. Baba Cardiac remodeling after long term norepinephrine treatment in rats Cardiovasc Res 52 2001 265 273
41. T. Ohtsuka, M. Hamada, H. Saeki, A. Ogimoto, Y. Hara, and Y. Shigematsu Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels Am J Cardiol 91 2003 1024 1027
42. K. Kawai, F. Qin, J. Shite, W. Mao, S. Fukuoka, and C.S. Liang Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy Am J Physiol Heart Circ Physiol 287 2004 H1003 H1012